BioSpace News Archive

Business

Taiho Oncology Names Timothy Whitten President

Taiho Oncology today announced the promotion of Timothy Whitten from Senior VP and COO to President, effective January 1, 2018.

January 3, 2018
·
6 min read
Deals

NovaQuest Capital Management to Acquire Viamet Pharmaceuticals and the VT-1161 Antifungal Program

Upon closing of the acquisition, Viamet Pharmaceuticals will be a portfolio company of NovaQuest Capital, which will focus on further development of VT-1161 and related assets.

January 3, 2018
·
6 min read
Genetown

Synspira Announces $3 Million Development Award From Cystic Fibrosis Foundation

Synspira today announced that it has received up to a $3 million award from the Cystic Fibrosis (CF) Foundation to advance clinical development of its lead candidate, SNSP113, for use in pulmonary complications of cystic fibrosis (CF).

January 3, 2018
·
3 min read
Business

Proclara Biosciences Strengthens Leadership Team with Appointment of David Michelson, M.D., as Chief Medical Officer

Dr. Michelson joins Proclara from Merck Research Laboratories, where he served for over a decade as Vice President and Therapeutic Area Head with responsibility for clinical research in Neuroscience, Pain, Anesthesiology and Ophthalmology.

January 3, 2018
·
3 min read
Business

FLX Bio Appoints Dirk G. Brockstedt, Ph.D., as Senior Vice President of Biology

Dr. Brockstedt joins FLX Bio most recently from Aduro Biotech, where he served in a number of escalating positions, most recently as Executive Vice President of Research and Development.

January 3, 2018
·
3 min read
VolitionRx Limited Releases Letter to Shareholders Including Status Update on Key Clinical Milestone

In the letter, Mr. Reynolds outlines several significant accomplishments to date and highlights the fact that the company believes that it is close to achieving a key clinical milestone with the completion of a 680-subject trial for the Nu.Q Frontline Asymptomatic Colorectal Cancer Screening Test.

January 3, 2018
·
6 min read
Policy

PharmaMar Has Requested the Process of Re-Examination for Aplidin From the EMA

PharmaMar has announced the initiation of the re-examination process by the EMA for Aplidin for the indication of relapsed and refractory multiple myeloma.

January 3, 2018
·
1 min read
Business

resTORbio Appoints Lynne Sullivan to Its Board of Directors

resTORbio announced that Lynne Sullivan, Senior Vice President of Finance for Biogen, Inc. has joined the resTORbio board of directors as an independent director.

January 3, 2018
·
4 min read
Business

Orbis Biosciences Announces Licensing Agreement With Reckitt Benckiser

The technology will enable new products for a leading segment of RB’s product portfolio. Detailed financial terms were not disclosed.

January 3, 2018
·
2 min read
Deals

China Biologic Announces Completion of Acquisition of TianXinFu From PWM

China Biologic Products today announced that it has completed the acquisition of 80% equity interest in Tianxinfu from PW Medtech Group Limited.

January 3, 2018
·
2 min read